Skip to main content
. 2023 Apr 5;53(15):7087–7095. doi: 10.1017/S0033291723000430

Table 1.

Descriptive characteristics of study population (n = 20)

Placebo (n = 10) Valaciclovir (n = 9) p value
Age (years) 35.4 ± 10.1 34.2 ± 4.7 0.739
Male (n) 8 7 1.000
Dutch ethnicity (n) 9 9 1.000
High education level# (n) 5 6 1.000
Duration of illness (years) 9.4 ± 8.1 9.9 ± 6.6 0.882
Diagnosis (n) (Code 295.xx)
Schizophrenia 8 8
Schizoaffective 2 1
Schizophreniform 0 0
Medication use
Modern antipsychotics 9 8
Classic antipsychotics 1 1
Antidepressant addition 4 3
Other addition 3 2

#Senior general secondary education, pre-university education, higher professional education or university education.